NovaBridge Biosciences
NBP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001778016
In the last 90 days, NovaBridge Biosciences insiders filed 0 open-market purchases and 4 sales; 49 institutions reported holding it in 13F filings for Q2 2026, worth $48.1M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
13F holders, Q2 2024
Institutional positions in NovaBridge Biosciences as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- −1 vs. Q1 2024
- Shares held
- 15.1M
- +2.95M (+24.2%) vs. Q1 2024
- Total value
- $25.3M
- +$2.65M (+11.7%) vs. Q1 2024
- New holders
- 3
- 5 more added
- Sold out
- 4
- 18 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NBP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 49 | $48.1M |
| Q1 2026 | 48 | $72.1M |
| Q4 2025 | 57 | $132.1M |
| Q3 2025 | 42 | $112.3M |
| Q2 2025 | 32 | $22.7M |
| Q1 2025 | 29 | $7.41M |
| Q4 2024 | 28 | $10.1M |
| Q3 2024 | 28 | $17.6M |
| Q2 2024 | 38 | $25.3M |
| Q1 2024 | 39 | $22.7M |
| Q4 2023 | 44 | $23.5M |
| Q3 2023 | 47 | $20.1M |
| Q2 2023 | 48 | $55.9M |
| Q1 2023 | 53 | $71.6M |
| Q4 2022 | 69 | $103.9M |
| Q3 2022 | 75 | $123.3M |
| Q2 2022 | 97 | $430.3M |
| Q1 2022 | 120 | $654.5M |
| Q4 2021 | 132 | $1.85B |
| Q3 2021 | 145 | $2.61B |
| Q2 2021 | 136 | $2.38B |
| Q1 2021 | 80 | $1.13B |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding NovaBridge Biosciences; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 6,909,220 | $11.5M | 0.28% | 00.0% | Unchanged |
| Caligan Partners LP | 3,374,791 | $5.64M | 1.32% | +2,618,253+346.1% | Added |
| Boothbay Fund Management, LLC | 1,379,352 | $2.30M | 0.07% | +1,001,083+264.6% | Added |
| Two Sigma Advisers, LP | 576,600 | $962.9K | 0.00% | −40,500−6.6% | Reduced |
| Temasek Holdings (Private) Ltd | 566,650 | $946.3K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 478,442 | $799.0K | 0.00% | −97,138−16.9% | Reduced |
| Gsa Capital Partners LLP | 272,193 | $455.0K | 0.03% | −160,428−37.1% | Reduced |
| Exome Asset Management LLC | 271,400 | $453.2K | 0.40% | −54,362−16.7% | Reduced |
| Bank of Montreal | 244,875 | $453.0K | 0.00% | +244,875 | New |
| EDBI Pte Ltd | 222,136 | $371.0K | 0.42% | 00.0% | Unchanged |
| Standard Life Aberdeen plc | 162,580 | $271.5K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 102,961 | $171.9K | 0.00% | −7,412−6.7% | Reduced |
| Alberta Investment Management Corp | 74,723 | $124.8K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 63,800 | $106.5K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 58,358 | $97.5K | 0.00% | −2,049−3.4% | Reduced |
| Invesco Ltd. | 57,933 | $96.7K | 0.00% | −27,211−32.0% | Reduced |
| Millennium Management LLC | 40,308 | $67.3K | 0.00% | −53,200−56.9% | Reduced |
| Citadel Advisors LLC | 38,708 | $64.6K | 0.00% | +38,708 | New |
| Geode Capital Management, LLC | 34,347 | $57.4K | 0.00% | 00.0% | Unchanged |
| Mariner, LLC | 31,535 | $52.7K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 31,066 | $51.9K | 0.00% | +31,066 | New |
| Barclays PLC | 30,370 | $50.7K | 0.00% | −8,182−21.2% | Reduced |
| Donald L. Hagan, LLC | 30,000 | $50.1K | 0.03% | 00.0% | Unchanged |
| XTX Topco Ltd | 17,876 | $29.9K | 0.00% | −12,609−41.4% | Reduced |
| Goldman Sachs Group Inc | 15,750 | $26.3K | 0.00% | −69,191−81.5% | Reduced |
| Marshall Wace, LLP | 14,064 | $23.5K | 0.00% | −57,024−80.2% | Reduced |
| Morgan Stanley | 13,880 | $23.2K | 0.00% | +3,771+37.3% | Added |
| UBS Group AG | 12,514 | $20.9K | 0.00% | +11,183+840.2% | Added |
| BlackRock Inc. | 7,684 | $12.8K | 0.00% | −239−3.0% | Reduced |
| Qube Research & Technologies Ltd | 2,565 | $4.28K | 0.00% | −1,500−36.9% | Reduced |
| Rhumbline Advisers | 1,367 | $2.28K | 0.00% | −4−0.3% | Reduced |
| Legal & General Group Plc | 1,191 | $1.99K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 568 | $949 | 0.00% | −18,289−97.0% | Reduced |
| Frazier Financial Advisors, LLC | 515 | $861 | 0.00% | +140+37.3% | Added |
| Catalyst Funds Management Pty Ltd | 90 | $150 | 0.00% | −146,200−99.9% | Reduced |
| GAMMA Investing LLC | 63 | $105 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 50 | $84 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 145 | $0 | 0.00% | −1,499−91.2% | Reduced |
| Man Group plc | 0 | $0 | 0.00% | −134,977−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −81,262−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −29,612−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −84−100.0% | Sold out |